Dalton's Lymphoma Ascites Cell Lines Research Articles

Anticancer Activity of the Bioactive Extract of the Morel Mushroom (Morchella elata, Ascomycetes) from Kashmir Himalaya (India) and Identification of Major Bioactive Compounds.

Morel mushrooms, Morchella species are highly nutritional, excellently edible and medicinal. Anticancer activity of M. elata, growing in forests of Kashmir Himalaya was studied. Ethyl acetate extract of fruiting bodies of M. elata (MEAE) was evaluated for cytotoxicity by MTT assay using Daltons lymphoma ascites (DLA), human colon cancer (HCT-116) and normal cell lines. Anti-carcinogenic and antiangiogenic activities of MEAE were tested using mouse models. Proapoptotic activity was detected by double staining of acridine orange-ethidium bromide assay. MEAE was partially purified by column chromatography and the bioactive compounds were identified by LC-MS analysis. The bioactive extract of M. elata showed significant cytotoxicic activity against DLA (P < 0.05), HCT-116 cell lines (P < 0.05) and did not possess appreciable adverse effect on the viability of normal cells. At a concentration of 100 µg/mL, 60% cell death was observed in HCT-116 cell line while 80% cell death was found in DLA cell line. The extract also possessed profound anticarcinogenic, antiangiogenic and proapoptotic activities. LC-MS analysis showed celastrol (RT 9.504, C29H38O4, MW 450.27), convallatoxin (RT 9.60, C29H42O10, MW 550.27), cucurbitacin A (RT 11.97, C32H46O9, MW 574.71) and madecassic acid (RT 14.35, C30H48O6, MW 504.70) as the major bioactive components. Current experimental studies indicated that bioactive extract of M. elata possessed significant anticancer activity. Being an excellently edible mushroom, the potential therapeutic use of M. elata and its bioactive extract in complementary therapy of cancer is envisaged.

4-Anilino Quinazoline Derivatives: Molecular Docking and Evaluation of In vitro Cytotoxic Activity

A novel scaffold of 4-anilino quinazoline derivatives was designed on the basis of known inhibitor of quinazoline based drugs. The designed derivatives were synthesized using optimized reaction condition. Their structures were confirmed by FT-IR, 1H-NMR, 13C-NMR and Mass spectral data. The structures of synthesized compounds were subjected to in silico  molecular docking using AutoDock software against the target Poly (ADP-ribose) polymerase-1 (PARP-1) enzyme. The compounds were evaluated for their in vitro cytotoxic activity against Daltons Lymphocyte Ascites (DLA) Cell lines. Molecular docking study of the newly synthesized compounds showed good binding mode in the active site of PARP-1. The docking results were compared with the standard drug Doxorubicin. Doxorubicin showed binding energy of -8.94 kcal/mol and formed one hydrogen bond with Asn767 with a distance of 1.98 Å. Compound SMOQ2 showed the least binding energy, i.e., 11.87kcal/mol and formed one hydrogen bond with Arg 878 with a distance of 1.895.A° Compound DMUQ5 showed binding energy of -11.42 kcal/mol and produced two hydrogen bonds with Arg 878 and Asn 767. Among the synthesized compounds, compounds SMOQ2 and DMUQ5 showed significant binding affinity compared to the standard drug Doxorubicin. The in vitro cytotoxic evaluation indicated that compounds SMOQ2 and DMUQ5 showed significant cytotoxic activity against Daltons Lymphoma Ascites cell line.

In vitro anticancer potential of Anaphyllum wightii Schott. against Dalton’s lymphoma ascites cell lines and molecular docking studies of β-sitosterol

Cancer is the second most life threatening noncommunicable disease in humans that challenges the mankind with its multifactorial etiology. Even though various treatment strategies such as radiation therapy, chemotherapy, etc. are commonly used for this disease, researches are being focussed on developing plant-derived novel anticancer compounds that lack side effects . There were no previous reports on the anticancer potential of the ethnomedicinally important plant Anaphyllum wightii Schott . (Araceae). Hence, in the present study, we evaluated the in vitro cytotoxic effects of A. wightii on Dalton’s lymphoma ascites (DLA) tumor cell line. Interestingly, the acetone extract of rhizome showed much lower LC 50 value (14.27 μg/ mL) for the DLA cell line compared to that of normal rat spleen cells (1189.23 μg/mL), revealing its significant anticancer potential. The molecular docking analysis showed β-sitosterol, present in the rhizome, as a promising lead molecule for the development of cytochrome P450 1 A1 inhibitors, which may provide potential anticancer agents

Cu(II) and Zn(II) complexes from a thiosemicarbazone derivative: Investigating the intermolecular interactions, crystal structures and cytotoxicity

Two complexes of Cu(II) and Zn(II) were prepared from a thiosemicarbazone derivative (H 2 esct) using their corresponding metal acetates and 2,2′-bipyridine as base. The complexes were characterized by elemental analyses, UV–visible, FT-IR and NMR spectroscopy. The structure of the thiosemicarbazone derivative and its five coordinated complexes were also determined by the single crystal X-ray diffraction study. Copper complex got crystallized in triclinic P 1 ¯ space group and zinc complex in monoclinic P 2 1 / c space group. The crystal structures of the complexes exhibited different types of intermolecular interactions, which have been further analyzed by Hirshfeld surface analysis and fingerprint plots. The in vitro cytotoxicity against Dalton lymphoma ascites cell lines showed that the Zn(II) and Cu(II) complexes are more cytotoxic than their corresponding proligand. • A new thiosemicarbazone and some of its transition metal(II) complexes were synthesized. • The compounds were characterized using spectroscopic techniques such as IR, UV–Vis, NMR etc . • Single crystal X-ray analysis confirmed that during complexation, the ligand acts as tridentate ONS donor forming five coordinateded geometry. • Visual analysis of short contacts was achieved through Hirshfeld surface analysis. • Cu(II) complex exhibited greater cytotoxicity as compared to a standard drug molecule.

IN VITRO CYTOTOXICITY ACTIVITY OF METHANOLIC LEAF AND FRUIT EXTRACT OF ZANTHOXYLUM OVALIFOLIUM WIGHT AGAINST DALTON’S LYMPHOMA ASCITES AND EHRLICH ASCITES CARCINOMA CANCER CELL LINES

Objectives: The objective of the present study, the methanolic leaf and fruit extraction of Zanthoxylum ovalifolium, was examined for in vitro cytotoxicity using trypan blue dye exclusion technique.&#x0D; Methodology: In vitro cytotoxicity activity of methanolic leaf and fruit extracts of Z. ovalifolium. Against Dalton’s lymphoma ascites (DLA) and Ehrlich ascites carcinoma (EAC) cell lines evaluated using trypan blue exclusion method. Non-viable cell absorbs blue color of trypan blue while viable cell does not absorb the dye. The percentage of total number of viable and non-viable cells is calculated using % viability=(live cell count/total cell count)×100.&#x0D; Results: Cytotoxicity activity of methanolic leaf and fruit extract against chosen tumor cell line at different concentrations of 10, 20, 50,100, and 200 μg/ml, respectively. The result confirmed that the fruit extract at 200 showed less toxic effect against DLA and EAC cell line showed 72% and 75% of inhibition growth of cell line and the most potent 80% and 82% of cell death were found in leaf extract against the chosen tumor cell line. The present study indicates that both leaf and fruit extract of Z. ovalifolium were appreciable antitumor activity against DLA and EAC cell lines may be due to the presence of phytochemicals such as flavonoids and alkaloids present in the plant.&#x0D; Conclusion: Zanthoxylum ovalifolium wight fruit and leaf methanolic extracts showed satisfying result of cytotoxicity activity against DLA and EAC cell line. Hence, Z.ovalifolium could be suggested as an important source of anticancer agent for pharmacological industries.

Design, Synthesis and Anticancer Activity of Site Specific Short Chain Cationic Peptide

In spite of current progress in treatment methods, cancer is a major source of morbidity and death rate all over the world. Traditional chemotherapeutic agents aim to divide cancerous cells, are often associated with deleterious side effects to healthy cells and tissues. Host defense peptides Cecropin A and B obtained from insects are capable to lyses various types of human cancer cells at peptide concentrations which are not fatal to normal eukaryotic cells. In the present work we have designed short chain α-helical linear and cyclic peptide from cecropin A having same cationic charge, hydrophobicity and helicity. Synthesis of designed novel short chain linear (10) and cyclic compound (12) was accomplished by using solution phase method. All the coupling reactions were carried out by using dicyclohexylcarbodiimide (DCC) as the coupling reagent at room temperature in the presence of N-methylmorpholine (NMM) as the base. The Structure of newly synthesized peptidse were elucidated by 1H-NMR, 13C-NMR, FT-IR, FABMS and elemental analysis data.Cytotoxicity of synthesized compound was tested against Dalton's Lymphoma Ascites (DLA), Ehrlich's Ascites Carcinoma (EAC) and MCF-7 cell lines by using MTT assay and 5-FU as reference compound. From biological assessment,it was found that short chain cyclicpeptide12 showed high level of cytotoxic activity against DLA and EAC cell lines. By utilizing a structure-based rational approach to anticancer peptide design from cecropin A, we were able to develop short chain linear and cyclic peptides having same charge, hydrophobicity and with improved activity. Systematically removing amino acids, we were able to retaining peptide charge and hydrophobicity/hydrophilicity in linear and cyclic peptide which results to optimize the anticancer activity against DLA and EAC cell lines.

IN VITRO ANTICANCER POTENTIAL OF BIOSYNTHESIZED ZINC OXIDE NANOPARTICLES FROM THE SEAWEED TURBINARIA CONOIDES

Objective: The objective of this study is to investigate the anticancer potential of zinc oxide nanoparticles (ZnO-NPs) and hydroethanolic extract of Turbinaria conoides (HETC) against Dalton’s lymphoma ascites (DLA) cell line. Methods: Nanoparticles were synthesized from the HETC. An ultraviolet-visible spectrophotometric analysis was performed to confirm the formation of ZnO-NPs. Size, morphology, and elemental composition of ZnO-NPs were also analyzed using scanning electron microscope-energy dispersive X-ray diffraction. The cytotoxic activity of ZnO-NPs and HETC was evaluated by 3-(4,5-dimethythiazol-. 2-yl)-2,5-diphenyltetrazolium bromide (MTT) and trypan blue dye exclusion assays on DLA cells. The apoptosis inducing the effect was observed through acridine orange staining method (AO and EB) and DNA ladder assay. Results: The results of in vitro cytotoxic studies by MTT and trypan blue dye exclusion assays on DLA cell line in the presence of ZnO-NPs showed an IC50 value of 23.13 and 25.81 μg/ml, respectively. The DNA ladder assay and AO/EB staining clearly demonstrated that the ZnO-NPs at 50 μg/ml concentration induced a maximum apoptosis in DLA cells when compared with HETC. Conclusion: In the present study, the cytotoxic and apoptotic inducing effect of the synthesized ZnO-NPs and HETC were assessed, and it was found that ZnO-NPs possessed potent anticancer effect against DLA cells.

EVALUATION OF IN VITRO ANTICANCER AND ANTIOXIDANT ACTIVITIES FROM LEAF EXTRACTS OF MEDICINAL PLANT CLIDEMIA HIRTA

Objective: To evaluate the anticancer and antioxidant activity of medicinal plant Clidemia hirta extracted in different solvents.Methods: Crude extracts were prepared from the leaves of Clidemia hirta using ethanol, petroleum ether and chloroform solvents. Anticancer activities and antioxidant properties were assayed using standard yellow dye 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) and 1, 1-diphenyl-2-picryl hydrazyl (DPPH) free radical scavenging assay respectively.Results: We found that the ethanol extract had higher inhibition activities against Dalton’s lymphoma ascites (DLA) cancer cell line, 50% DLA cell line inhibition at 68µg/ml, while 50% inhibition by petroleum ether and chloroform extracts were at 160µg/ml and 172µg/ml, respectively. The antioxidant activity requires5µg/ml of ethanol extract to trap 50% of DPPH (IC50), whereas the positive control ascorbic acid trapped 50% of DPPH (IC50) at 3.5µg/ml.Conclusion: The prepared leaf extracts with different solvents of Clidemia hirta showed the antiproliferative and antioxidant activity in dose-dependent manner. Further works is required to identify the biologically active chemical constituents, responsible for cancer cell growth inhibition from this plant.

&lt;i&gt;In Vitro&lt;/i&gt; Anticancer Activity of Ethanolic Extract of &lt;i&gt;Euphorbia hirta&lt;/i&gt; (L.)

In the present study, In vitro anticancer effects of Euphorbia hirta were investigated. The objectives of this study are to find the presence of secondary metabolites by preliminary phytochemical investigation and FTIR analysis in the Euphorbia hirta. Ethanolic leaf extract of Euphorbia hirta was tested for its cytotoxicity against Dalton Lymphoma Ascites (DLA) and Ehrlich Ascites Carcinoma (EAC) cell lines using preliminary screening technique (Trypan Blue method and standard MTT colorimetric method). The Euphorbia hirta leaf extract was found to be more cytotoxic against Ehrlich Ascites Carcinoma cell lines when compared to cytotoxic activity against Dalton Lymphoma Ascites cell lines where as 59.67% cytotoxicity were noticed against Ehrlich Ascites Carcinoma cell lines. Extract of Euphorbia hirta showed a dose-dependent reduction of proliferation and induction of apoptosis in the Carcinoma cell lines cells. Ethanolic leaf extract of Euphorbia hirta showed potent cytotoxic activity against DLA and EAC cell lines and its IC50 value was found to be 560.83ìg/ml and 384.7 ìg/ml of extract respectively. The in vitro outcomes of Euphorbia hirta extract showed potent anticancer effect against both DLA and EAC cell lines.

Antitumor and antimicrobial activities and inhibition of in-vitro lipid peroxidation by Dendrobium nobile.

The aim of the study was to determine the antitumor and antimicrobial activities as well as the inhibition of in vitro lipid peroxidation evoked by Dendrobium nobile. Antimicrobial activity of different solvent extracts of flowers and stem of D. nobile against Escherichia coli, Bacillus subtilis, Proteus, Salmonella typhi and Staphylococcus aureus were analyzed separately. The swiss albino mice were induced with Dalton’s Lymphoma Ascites (DLA) cell lines and the antitumor effect of D. nobile was studied by administering orally the aqueous extracts of the flowers of D. nobile. The antitumor activity was measured in DLA cell line induced mice. Inhibition of in vitro lipid peroxidation activity of the D. nobile in both liver homogenate and RBC ghosts was also carried out. The aqueous extracts of stem and flower of D. nobile showed better zone of bacterial inhibition than that of ethanol and chloroform extracts. The plant extracts treated DLA cell induced mice showed better tumor regression, and the flowers of the plant inhibited the in vitro lipid peroxidation, significantly. The present work indicates that the D. nobile flower extracts possessed antimicrobial and antitumor properties in addition to antiperoxidative activity.

Proapoptotic and antitumor activities of the HMG-CoA reductase inhibitor, lovastatin, against Dalton's Lymphoma Ascites tumor in mice

Background Diet rich in fat have a clear effect on the tumor incidence in humans. Increased level of lipid peroxidation were found in colon, liver, breast and kidney carcinogenesis. Although the beneficial effects of statins for cardiovascular diseases are well established, their importance in the area of cancer therapeutics has recently gained recognition. Many studies of lovastatin in in vitro systems and experimental animals have been reported as an effective antitumor agent. However, phase I/II clinical trials in cancer patients demonstrated a minor to non-significant responses. Hence more studies in different tumor models using doses corresponding to that used to reduce lipid in human are required to support the antitumor activity. Methods The antitumor activity was evaluated using Daltons' Lymphoma Ascites (DLA) cell line-induced ascites tumor model in mice. Proapoptotic activity was evaluated in DLA cell line induced ascites animals after the treatment of lovastatin. Apoptosis was analyzed morphologically by staining with Giemsa and biochemically by observing the laddering of DNA in agarose gel electrophoresis. In vitro cytotoxic activity of lovastatin was studied by trypan blue dye exclusion method. Lipid peroxidation inhibiting activity was demonstrated in Fe 2+-ascorbate induced rat whole liver homogenate. Results Lovastatin dose dependently inhibited the ascites tumor growth at 4 and 16 mg/kg body wt (p.o). The percentage increase in life span (%ILS) in the 16 mg/kg treated group was 61.8% ( P < 0.01). Single dose of lovastatin (16 mg/kg body wt, p.o) was also effective to accelerate the apoptosis in the ascites tumor bearing mice that was evident from the multiple fragmentation of DNA in gel electrophoresis. Further the morphological analysis of DLA cells aspirated from the lovastatin treated animals showed a significant ( P < 0.01) increase of apoptotic cells (15.5 ± 3%) than the control animals (6.5 ± 1%). Concentration of lovastatin required for the 50% of the cytotoxicity was 37 ± 5 μg/ml. Lovastatin at its low concentrations were effective to inhibit lipid peroxidation. Conclusions The antitumor activity of lovastatin against the ascites tumor is due to its proapoptotic and cytotoxic activities. Lovastatin at low concentrations inhibited Fe 2+ induced lipid peroxidation in in vitro system. The proapoptotic and lipid peroxidation inhibiting activities of the lipid lowering drug lovastatin may further suggest its possible therapeutic use as a cancer chemopreventive agent.

Effect of Aerva lanata on solid tumor induced by DLA cells in mice

Aerva lanata whole plant was extracted with petroleum ether, methanol and acetone. The partially TLC-purified fraction (PEF) of petroleum ether extract was proved to be cytotoxic to Dalton's lymphoma ascites (DLA), Ehrlich ascites (EA) and B16F10 cell lines in vitro. Since PEF was found to be more cytotoxic to DLA cell lines, it was used to study the pharmacological effect and its potential to reduce solid tumor induced by DLA cell lines in mice. The result indicated that PEF significantly reduced the development of solid tumor in mice.

Cytotoxic and antitumor activities of a polypore macrofungus, Phellinus rimosus (Berk) Pilat.

Cytotoxic and antitumor activities of ethyl acetate, methanol and aqueous extracts of a wood inhabiting polypore macrofungus, Phellinus rimosus (Berk) Pilat. were studied. Ethyl acetate and methanol extracts showed in vitro cytotoxic activity against Dalton's lymphoma ascites (DLA) and Ehrlich's ascites carcinoma (EAC) cell lines. The aqueous extract did not exhibit cytotoxicity against the tested cell lines. All the three extracts were highly effective in inhibiting growth of solid tumor induced by DLA cell line in mice. However, the antitumor activity of ethyl acetate extract was higher than that of methanol and aqueous extracts. The ethyl acetate extract was also effective in preventing the EAC induced ascites tumor development in mice. The antitumor activity of all the three extracts against solid tumor at a dose of 50 mg/kg (p.o.) was comparable to the clinically used standard reference drug, cisplatin (4 mg/kg, i.p.). Pre-treatment of the extracts was also effective in inhibiting the tumor growth induced by DLA cell lines. The experimental results revealed that ethyl acetate extract of P. rimosus possessed significant antitumor activity. The findings thus suggest the potential use of this mushroom as antitumor agent.